PHOTOGEM®
is the unique photodynamic drug therapy (PDT) of malignant tumours.
In 1996 clinical probations of PHOTOGEM® were successfully
completed. More then 1500 patients have undergone courses of Photogem®
medical treatment (PDT courses) by now.
Acute form of therapeutic effect was observed in 91% of the cases. A
complete disappearance of malignant growth was obtained in 62% of the
cases, and a partial regression (decrease of a tumour more than twice)
was obtained in 29% of the cases. At the early cancer stages complete
recovery of patients was observed in 92 % of the cases.
According to the leading oncologists conclusion PHOTOGEM®
medical treatment is a challenging, perspective high-performance
photodynamic drug therapy for cancer.
PHOTOGEM® was registered and approved by Ministry of Health
of Russian Federation (order of MHRF #47, 10th of February,
1999).
The description of photosensitizer PHOTOGEM® see here.